fda semaglutide shortage resolved february 21 2025 Ends: Compounded Versions Legal Battle FDA Declares Wegovy and Ozempic
Description
Semaglutide-associated worsening of atypical anorexia nervosa in an adolescent girl: case report
Wegovy has shown promising results in clinical trials, with participants achieving rapid weight loss and significant improvements in blood pressure and blood sugar control
Medeiros M
Cutting back on caffeine later in the day can prevent frequent bathroom trips at night
Medical costs are 2.3 times higher in patients with diabetes, with health care expenditures exceeding $174 billion annually
Botulinum toxin for refractory postoperative pyloric spasm
